Stephen M. Taylor - Concepedia

Author

Stephen M. Taylor

Also Known As

, S M TAYLOR, S M Taylor, S Taylor, S. M. Taylor, S. TAYLOR, S. Taylor, S.M. Taylor, STEPHEN M. TAYLOR, Stephen M Taylor

215

Publications

9.9K

Citations

H-Index

220

Concepts

All Affiliations

The University of Queensland Washington State University University of Nebraska Medical Center University of Sheffield

About

Stephen M. Taylor is an author at The University of Queensland specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	12	15	550
2	Health Sciences	5	5	450
3	Education	1	1	10
4	Humanities	1	1	20
5	Language Studies	1	1	20

Stephen M. Taylor

131

Publications

7.8K

Citations

H-Index

Page 1

	Year	Citations
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke Trent M. Woodruff, John Thundyil, Sung‐Chun Tang, Molecular Neurodegeneration	2011	587
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer’s Disease María Isabel Fonseca, Rahasson R. Ager, Shu-Hui Chu, The Journal of Immunology	2009	272
Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a Angela M. Finch, A. K. Wong, Natalii J. Paczkowski, Journal of Medicinal Chemistry Nmr SpectroscopyImmunologyImmune RegulationComplement Factor C5aHuman Complement System	1999	242
Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic rats Goran Miric, Catherine Dallemagne, Zoltán Endre, British Journal of Pharmacology Renal InflammationCardiovascular PharmacologyRenal FibrosisPharmacotherapyStreptozotocin‐diabetic Rats	2001	211
A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats Thiruma V. Arumugam, Ian A. Shiels, Anna J. Strachan, Kidney International InflammationMolecular PharmacologyMolecular PhysiologyIschemia/reperfusion InjuryMedicine	2003	203
The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. Steven E. McKenzie, Stephen M. Taylor, Padmini Malladi, PubMed Immune ClearanceImmunologyBlood CellImmunologic MechanismTransgenic Mouse Model	1999	187
Characterisation of zuclopenthixol metabolism by <i>in vitro</i> and therapeutic drug monitoring studies Simon Davies, Andreas Austgulen Westin, Ingrid Castberg, Acta Psychiatrica Scandinavica	2010	176
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization Mike C. L. Wu, Faith H. Brennan, Jason P. Lynch, Proceedings of the National Academy of Sciences	2013	163
The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System Trent M. Woodruff, Rahasson R. Ager, Andrea J. Tenner, NeuroMolecular Medicine Complement SystemNeurophysiologyNeuroanatomyMedicinePhysiology	2009	158
The Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis Trent M. Woodruff, K.J. Costantini, James W. Crane, The Journal of Immunology	2008	156

Page 1